The Appropriate Blood Pressure Control in Diabetes (ABCD) Trial has been a major research activity of the Colorado Prevention Center for the past 12 years.
This study, one of the largest single-site studies ever performed,
evaluated 950 randomized diabetic patients. The initial phase of
the study was completed in 1998.
The study objective was to define the role of intensive
versus moderate blood pressure lowering in individuals with Type 2 diabetes.
Additionally, the research compared certain drug therapies
and their association with cardiovascular complications in Type 2 diabetes.
Robert Schrier, MD, Ray Estacio, MD, and other CPC researchers
continue to
disseminate findings
from the
first phase of the trial in medical journals, meetings, and educational symposia.
For further information about the ABCD research,
please see our
press release.
|
